Review: taking Warfarin sodium and Flurbiprofen together


Summary

Drug interactions are reported among people who take Warfarin sodium and Flurbiprofen together. This review analyzes the effectiveness and drug interactions between Warfarin sodium and Flurbiprofen. It is created by eHealthMe based on reports of 28 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Warfarin Sodium

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Warfarin sodium 53,624 users)

Flurbiprofen

Flurbiprofen has active ingredients of flurbiprofen. It is often used in rheumatoid arthritis. (latest outcomes from Flurbiprofen 1,433 users)

On Sep, 18, 2016

28 people who take Warfarin Sodium, Flurbiprofen are studied.


Number of reports submitted per year:

Warfarin sodium and Flurbiprofen drug interactions.

Drug effectiveness over time:

Warfarin Sodium:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Flurbiprofen:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Warfarin Sodium:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (1 of 1 people)
Flurbiprofen:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Warfarin Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 100.0% - (1 of 1 people)
Flurbiprofen:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • decreased appetite
  • pancytopenia
  • renal impairment
  • abdominal discomfort
  • abdominal distension
  • abdominal pain
  • anaemia
  • anxiety
  • aortic aneurysm rupture
  • aortic dilatation
1 - 6 months:
  • decreased appetite
  • deep vein thrombosis
  • liver disorder
  • oedema peripheral
  • pancytopenia
  • renal impairment
  • upper respiratory tract infection
6 - 12 months:
  • dermatitis exfoliative
  • dry skin
  • pruritus
1 - 2 years:
  • haematoma
  • haemoglobin decreased
  • international normalised ratio increased
  • pain in extremity
5 - 10 years:
  • asthenia
  • atrial fibrillation
  • gait disturbance
  • hypoalbuminaemia
  • hypokalaemia
  • lactic acidosis
  • pneumonia
  • pulmonary embolism
  • rectal haemorrhage
  • shock
not specified:
  • pulmonary embolism
  • deep vein thrombosis
  • pain
  • c-reactive protein increased
  • anaemia
  • dyspnoea exertional
  • pain in extremity
  • urinary tract infection
  • back pain
  • hypokalaemia

Most common drug interactions by gender *:

female:
  • pulmonary embolism
  • deep vein thrombosis
  • pain
  • anaemia
  • c-reactive protein increased
  • diverticulum
  • dyspnoea exertional
  • muscle spasms
  • pain in extremity
  • swelling
male:
  • tachypnoea
  • cardiac failure
  • congestive cardiomyopathy
  • ejection fraction decreased
  • hypotension
  • international normalised ratio increased
  • intracardiac thrombus
  • mitral valve incompetence
  • multiple injuries
  • pulmonary hypertension

Most common drug interactions by age *:

20-29:
  • activities of daily living impaired
  • altered state of consciousness
  • anaemia
  • c-reactive protein increased
  • clavicle fracture
  • constipation
  • contusion
  • disuse syndrome
  • dry skin
  • fall
40-49:
  • deep vein thrombosis
  • dyspnoea exertional
  • muscle spasms
  • pain
  • pain in extremity
  • pulmonary embolism
  • swelling
  • homans' sign
  • oedema peripheral
  • altered state of consciousness
50-59:
  • deep vein thrombosis
  • abscess rupture
  • anaemia
  • back pain
  • c-reactive protein increased
  • diverticulum
  • rheumatoid arthritis
  • urinary tract infection
  • cardiac failure
  • congestive cardiomyopathy
60+:
  • pancytopenia
  • international normalised ratio increased
  • lactic acidosis
  • abdominal pain
  • asthenia
  • decreased appetite
  • insomnia
  • nausea
  • renal impairment
  • vomiting

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Warfarin sodium and Flurbiprofen?

Can you answer these questions?

More questions for: Warfarin sodium, Flurbiprofen

You may be interested in these reviews

More reviews for: Warfarin sodium, Flurbiprofen

On eHealthMe, Warfarin sodium (warfarin sodium) is often used to treat atrial fibrillation/flutter. Flurbiprofen (flurbiprofen) is often used to treat rheumatoid arthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.